addiction Flashcards
pharmacology of drugs of abuse: summarise the pharmacokinetics and pharmacology of the main drugs of abuse: cannabis, nicotine, cocaine, alcohol and opioids
4 commonest routes of administration for main drugs of abuse
snort (intra-nasal), eat/drink (oral), smoke (inhalation), inject (i.v)
intra-nasal administration: location and rate of absorption
mucous membranes of nasal sinuses; slow absorption (diffuses into venous system)
oral administration: location and rate of absorption
GI tract; very slow absorption
inhalation administration: location and rate of absorption
small airways and alveoli; very rapid absorption (minimal resistance to flow and already in pulmonary circulation)
i.v administration: location and rate of absorption
veins; rapid absorption
4 pharmacological classifications of drugs of abuse
narcotics/painkillers, depressants (‘downers’), stimulants (‘uppers’), miscellaneous
examples of narcotics/painkillers
opiate-like drugs e.g. heroin
examples of depressants
alcohol, benzodiazepines (valium), barbiturates
examples of stimulants
cocaine, amphetamine (‘speed’), caffeine metamphetamine (‘crystal meth’), nicotine
examples of miscellaneous (have other properties)
cannabis, ecstasy (MDMA)
forms of cannabis
cannabis/marijuana, hashish/resin (trichomes - glandular hairs), hash oil (solvent extraction)
number of compounds and cannabinoids in cannabis
> 400 compounds, >60 cannabinoids (n glandular hairs)
2 primary cannabinoids of cannabis, and onset of cannabis
cannabidiol and THC (most powerful); seconds->minutes
dosing in cannabis plant: reefer (60s-70s) vs skunkweed/netherweed (21st century) and relevance
10mg THC vs 150-300mg THC; farmed to increase amount of THC in plant, so more powerful effect (if increase dose, hit ceiling of positive symptoms, but increasing risk of negative effects - cannabidiol moderates effects of THC, but with increased THC at expense of cannabidiol, elevation of negative effects)
administration of cannabis bioavailablity (% into bloodstream)
5-15% oral (delayed onset and slow absorption as fair amount of first pass metabolism by liver before entering blood stream), 25-35% inhalation (exhale about 50% back out again, and that 50% remaining must be deeply inhaled)
distribution of cannabis
diffuses freely from blood into organs, but overtime intensive accumulation occurs in less vascularised tissues and finally slowly accumulates in poorly perfused fatty tissues (long-term storage site as very lipid-soluble; reversible so slowly diffuses back into blood)
upon cannabis administration, what therefore builds up in fatty tissue
fatty acid conjugates of 11-OH-THC
concentration ratios of THC between fat and plasma
10^4 : 1
metabolism of cannabis: phase 1 metabolite location and name
liver to 11-hydroxy-THC (more potent than THC); liver can only conjugate (phase 2) so much per unit time
excretion of cannabis
65% GI tract into bile and faeces, 25% urine
what does cannabis undergo if excreted in bile as lipid-soluble
enterohepatic recycling
describe and explain correlation between plasma cannabinoid concentration and degree of intoxication
poor, as can measure plasma THC, but no info on 11-hydroxy-THC levels, levels in fat or enterohepatic recycling
describe cannabinoid diffusion to brain
structural fat in brain, so cannabinoids diffuse into and build up in brain, so 7-8x more THC in brain than blood (blood mainly has phase 2 conjugated form)
tissue half life of cannabis, and how long after smoking a cannabis cigarette will the effects persist in the body (remains in adipose tissue)
tissue half life of 7 days, but due to remaining in adipose tissue, effects persist for 30 days
what receptors does cannabis bind to
CB1, CB2 (cannabinoid receptor)
location of CB1 receptors
hippocampus, cerebellum, cerebral cortex, basal ganglia; most common G-protein coupled receptor in brain
location of CB2 receptors
immune cells
CB R type of receptor and hence type of drug and effect on IC enzymes
type 2 (G-protein coupled receptor), Gi/o (inhibitory) so depressant, depresing adenylate cyclase
CB R endogenous cannabinoid
endogenous anandamide
mesolimbic dopamine system resulting in euphoria
cannabis -> CB1 receptor on GABA interneurone -> reduction in GABA (natural suppressant) release to ventral tegmental area (disinhibition) -> high dopamine release from nucleus accumbens
5 central effects of cannabis
euphoria, psychosis (and schizophrenia), increased appetite, memory loss, psychomotor performance
what is the role of the anterior cingulate cortex
involved with performance monitoring with behavioural adjustment in order to avoid losses (error detection, and adapts behaviour by detecting and focusing on goal-relevant information, and selecting most appropriate behaviour to avoid losses)
what does cannabis do to anterior cingulate cortex, and what 2 conditions can result
hypoactivity, losing ability to change behaviour, resulting in psychosis, schizoprenia (especially if just THC vs THC and cannabidiol, which induces more euphoria)
cannabis effect on food intake
leptin, ghrelin etc signal from body into arcuate nucleus (unaffected by cannabis) -> cannabis binds to CB1 R which causes presynaptic inhibition of GABA to lateral hypothalamus, increasing MHC neuronal activity; also directly causes an increase in orexin production -> increased appetite
cannabinoid agonists as immunosuppressants: 4 immune cells with CB R expression, and effect of cannabis on cells
B-cell, macrophage, natural killer cells, T-cell; suppresses their effect, so more susceptible to illness and infection
why does cannabis cause memory loss
affects limbic regions (amnestic effects, reducing BDNF which normally improves hippocampal health)
which area does cannabis suppress psychomotor performance
cerebral cortex
2 peripheral effects of cannabis
immunosuppressant, tachycardia/vasodilation (conjunctivae - blood shot eyes; affects TRPV1 as opposed to CB R)
effect of cannabis on medulla
low CB1 receptor expression, meaning that cardiovascular and cardiorespiratory control not suppressed (can’t overdose to point of death)
medical use of cannabis: 3 conditions where regulatory elevation of CB1 R
multiple sclerosis, pain, stroke
medical use of cannabis: 2 conditions where pathology elevation of CB1 R
fertility (up-regulate and decrease testosterone and pituitary gland with regard to gonad function, as well as sperm function), obesity (up-regulated in liver and adipose tissue)
medical use of cannabis ‘autoprotection’: what are dronabinol and nabilone (THC) used to treat
prevent nausea and vomiting caused by chemotherapy in those without good results using other medications
medical use of cannabis ‘autoprotection’: what is dronabinol used to treat
loss of appetite and weight loss in people with acquired immunodeficiency syndrome (AIDS)
medical use of rimonabant, and problem (hence taken off market)
anti-obesity agent as antagonist for CB R, decreasing weight; caused increased depression and suicide
medical use of cannabis: ‘autoprotection’ what is sativex (THC and cannabidiol) used to treat
symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis who have not responded adequately to other anti-spasticity medication, analgaesic
what does high potency fatty acid amide hydrolase do inhibitor
increases concentration of endogenous anandamide (natural agonist of CB R)
epidemiology of alcohol
high in Europe, Russia and US; low in north Africa (Islam)
dosing of alcohol: absolute amount vs units, and consistency of units
absolute amount is % alcohol by volume x 0.78 (g/100ml); units is % alcohol by volume x volume/1000, with 1 unit =10ml/8g of absolute alcohol; no consistency of units as volume changes (e.g. glass of wine)
dosing of alcohol: safe level
men and women <14 units/week is low risk; binge drinking (>8 units in one sitting)
dosing of alcohol: what does a blood level of 0.01% mean
10mg/100ml blood
dosing of alcohol: blood levels based on weight and blood level
charts which show weight and number of drinks, and estimated blood level (can subtract 0.01% for each 40 minutes due to metabolism)
administration route of alcohol
oral
administration of alcohol and effect on stomach fullness
20% to stomach, 80% to small intestine, so drinking on a full stomach reduces blood alcohol level as joins food and can’t reach outer sides of stomach to be absorber (20%), and as most (80%) absorbed in small intestine, doesn’t reach there for longer, so speed of onset is proportional to gastric emptying
% of alcohol metabolised, and % metabolised in liver
90% metabolised (10% excreted unmetabolised), with 85% of 90% metabolised in liver
metabolism pathway of alcohol in liver to acetaldehyde
alcohol -> [alcohol dehydrogenase (75%) or mixed function oxidase (25%)] -> acetaldehyde (toxic compound)
why is there tolerance to alcohol
liver upregulates mixed function oxidase, so liver more effective at metabolising it (reversible so if stop drinking for long time, enzymes won’t be upregulated)
metabolism of alcohol: role of first pass hepatic metabolism and breaking up alcohol dose over time
enzymes are all saturable, so can only metabolise at certain rate, so if all in one go the alcohol leaks into systemic circulation, increasing blood levels, whereas if smaller doses, enzymes have more time to metabolise, so blood levels much lower
% of alcohol metabolism in GI tract (stomach)
15%
metabolism pathway of alcohol in GI tract to acetaldehyde
alcohol -> [alcohol dehydrogenase] -> acetaldehyde
metabolism pathway of alcohol in GI tract: female levels of alcohol dehydrogenase in stomach
50% less alcohol dehydrogenase in stomach vs men
distribution of alcohol: men vs women
women have lower body water (50%) vs men (59%), which corresponds to a lower plasma level, and as less stomach alcoholic dehydrogenase, so alcohol less diluted in women and have less capacity to metabolise
metabolism of alcohol: metabolism of acetaldehyde in liver and GI tract
acetaldehyde (toxic compound) -> [aldehyde dehydrogenase] -> acetic acid
effect of disulfiram on aldehyde dehydrogenase, and clinical use
inhibits aldehyde dehydrogenase, causing a build up of acetaldehyde (toxic compound) and producing an acute sensitivity to alcohol, so used as alcohol aversion therapy as symptoms of hangover occur much more quickly with less alcohol
genetic polymorphism of aldehyde dehydrogenase
“Asian flush” -> less effective enzyme
potency of alcohol
low (ug/ml vs ng/ml for cocaine and nicotine) as simple chemical (binds to lots of targets, but not very well)
what chemical is alcohol, and hence pharmacological targets
ethanol (C2H5OH), so no pharmacological targets, so affinity and efficacy poor
acute effects of alcohol in CNS
primary effect is depressant, but CNS agitation might occur (low dose in certain situations)
what is degree of CNS excitability dependent on (low dose alcohol increases CNS excitability, but decreases at higher dose as depressant)
personality and environment (environment is non-social (low excitability) or social setting (high excitability))
acute effects of alcohol in CNS: direct and indirect effects on GABA receptors and Cl- influx
direct: increases GABA, promoting Cl- influx; indirect: increases release of allopregnenolone which binds to GABA receptors and promotes Cl- influx
acute effects of alcohol in CNS: effect on allosteric modulation of NMDA receptors
decrease
acute effects of alcohol in CNS: effect on neurotransmitter release, and reason
reduce, as Ca2+ channels decrease
2 factors influencing acute effects of alcohol on CNS
CNS is functionally complex, ethanol has low potency so low selectivity
how does alcohol cause an acute euphoric effect in CNS
opiates/alcohol bind to u-receptor on GABAergic neurone -> decrease in GABA release -> ventral tegmental area -> nucleus accumbens -> increase in dopamine release